Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to compare awake thoracic epidural anesthesia and general anesthesia in thoracotomy.
The severity of acute postoperative pain is a causative factor for chronic postsurgical pain, and it has been observed that the incidence of chronic postsurgical pain is very high after thoracotomy. Effective management of acute post-operative pain is a must in these patients.
Thoracic epidural analgesia (TEA) is used as an adjunct to general anesthesia (GA) in thoracic surgery. However, tthe horacic epidural blockade has been rarely utilized as a sole method to provide anesthesia for major thoracic procedures
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Awake thoracic epidural anesthesia group | Experimental | Patients will preoperatively receive awake thoracic epidural anesthesia. |
|
| General anesthesia group | Active Comparator | Patients will receive general anesthesia. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Awake thoracic epidural anesthesia | Drug | Patients will preoperatively receive awake thoracic epidural anesthesia. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Assessment the change in pulmonary function | The change in pulmonary function will be assessed using Forced vital capacity (FVC) will be recorded. | 24 hours postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Heart rate | Heart rate will be recorded at baseline, and every 15min till the end of surgery. | Till the end of surgery (Up to 2 hours) |
| Mean arterial pressure | Mean arterial pressure will be recorded at baseline, and every 15min till the end of surgery. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mohamed E Abdel Fattah, MD | Contact | 00201284475792 | mohamed-elsaid@cu.edu.eg |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo University | Recruiting | Cairo | 12613 | Egypt |
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
After the end of study for one year.
The data will be available upon a reasonable request from the corresponding author.
Not provided
Not provided
| ID | Term |
|---|---|
| D002045 | Bupivacaine |
| D000768 | Anesthesia, General |
| D005283 | Fentanyl |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| General anesthesia | Drug | Patients will receive general anesthesia. |
|
|
| Till the end of surgery (Up to 2 hours) |
| Degree of pain | The patients will be instructed how to report pain by means of the visual analogue scale (VAS), in which 0 = "no pain" and 10 = "worst possible pain". VAS will be assessed at post-anesthesia care unit (PACU), 1, 2, 4, 8, 12,18, 24, 36, 48 hours postoperative. | 48 hours postoperatively |
| Total morphine consumption | Rescue analgesia of morphine will be given as 3 mg bolus if the VAS > 3 to be repeated after 30 min if pain persists until the visual analogue scale (VAS) < 4. | 48 hours postoperatively |
| Time to 1st rescue analgesia | Time to 1st rescue analgesia (time from end of surgery to first dose of morphine administrated). | 48 hours postoperatively |
| Incidence of adverse events | Incidence of adverse events such as nausea, vomiting, and respiratory depression will be recorded. | 48 hours postoperatively |
| D000588 |
| Amines |
| D000758 | Anesthesia |
| D000760 | Anesthesia and Analgesia |
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |